All Stories

  1. Polyunsaturated fatty acid sequestration protects against mitochondrial dysfunction-induced ferroptosis
  2. FTO inhibition disrupts energy metabolism and reduces tolerance to hypoxia in cardiomyocytes
  3. The cytochrome c oxidase subunit COX6B1 is required for redox-sensitive early assembly and late stabilization of complex IV
  4. Development of Cellular Energy Metabolism During Differentiation of Human iPSCs into Cortical Neurons
  5. Sequestration of the polyunsaturated fatty acids protects the cells with oxidative phosphorylation deficiency from ferroptosis
  6. Germline Jak2-R1063H mutation interferes with normal hematopoietic development and increases risk of thrombosis and leukemic transformation
  7. Determination of ADP/ATP translocase isoform ratios in malignancy and cellular senescence
  8. COX6B1 secures a redox-sensitive step in early cytochrome c oxidase assembly
  9. Cryopreserved PBMCs can be used for the analysis of mitochondrial respiration and serve as a diagnostic tool for mitochondrial diseases
  10. Bioenergetics of human spermatozoa in patients with testicular germ cell tumours
  11. Haplotype variability in mitochondrial rRNA predisposes to metabolic syndrome
  12. Czech Footprints in the Bioenergetics Research
  13. Variability of Clinical Phenotypes Caused by Isolated Defects of Mitochondrial ATP Synthase
  14. Mitochondrial translation is the primary determinant of secondary mitochondrial complex I deficiencies
  15. Omega-3 PUFAs prevent bone impairment and bone marrow adiposity in mouse model of obesity
  16. Restored biosynthetic pathways induced by MSCs serve as rescue mechanism in leukemia cells after L-asparaginase therapy
  17. Hypolipidemic Effects of Beetroot Juice in SHR-CRP and HHTg Rat Models of Metabolic Syndrome: Analysis of Hepatic Proteome
  18. Restored Biosynthetic Pathways Induced By MSCs Serve As Rescue Mechanism in Leukemia Cells after L-Asparaginase Therapy
  19. Novel thiazolidinedione analog reduces a negative impact on bone and mesenchymal stem cell properties in obese mice compared to classical thiazolidinediones
  20. Ketogenic diet can reduce pathologic presentation of TMEM70 deficiency in animal models
  21. Metabolic adaptations triggered by impairment of cytochrome c oxidase
  22. Metabolic rewiring in a cellular model lacking ATP synthase
  23. Oxygen consumption measurements of cryopreserved PBMCs as a new diagnostic tool for mitochondrial diseases
  24. The role of SURF1 protein in cytochrome c oxidase biogenesis
  25. Transgenic rescue approach ameliorates ATP synthase deficiency caused by the dysfunction of TMEM70 assembly factor in rat
  26. Uncovering the OXPHOS complexes' interdependence mechanism
  27. Mitochondrial respiration supports autophagy to provide stress resistance during quiescence
  28. Genetic Complementation of ATP Synthase Deficiency Due to Dysfunction of TMEM70 Assembly Factor in Rat
  29. Conplastic strains for identification of retrograde effects of mitochondrial dna variation on cardiometabolic traits in the spontaneously hypertensive rat
  30. POLRMT mutations impair mitochondrial transcription causing neurological disease
  31. Role of Mitochondrial Glycerol-3-Phosphate Dehydrogenase in Metabolic Adaptations of Prostate Cancer
  32. Metabolic profile of leukemia cells influences treatment efficacy of L-asparaginase
  33. Cytochrome c Oxidase Subunit 4 Isoform Exchange Results in Modulation of Oxygen Affinity
  34. MLQ is responsible for stabilisation of subunit a in the holoenzyme of mammalian ATP synthase
  35. Biochemical thresholds for pathological presentation of ATP synthase deficiencies
  36. Mitochondrial targets of metformin—Are they physiologically relevant?
  37. Pleiotropic Effects of Biguanides on Mitochondrial Reactive Oxygen Species Production
  38. Mitochondrial Targeting of Metformin Enhances Its Activity against Pancreatic Cancer
  39. Pharmacological inhibition of fatty-acid oxidation synergistically enhances the effect of l-asparaginase in childhood ALL cells
  40. Noninvasive diagnostics of mitochondrial disorders in isolated lymphocytes with high resolution respirometry
  41. ROS production in brown adipose tissue mitochondria: The question of UCP1-dependence
  42. Cytochrome c oxidase subunit 4 isoform 2-knockout mice show reduced enzyme activity, airway hyporeactivity, and lung pathology
  43. Mice deleted for heart-type cytochrome c oxidase subunit 7a1 develop dilated cardiomyopathy
  44. Mitochondrially Targeted α-Tocopheryl Succinate Is Antiangiogenic: Potential Benefit Against Tumor Angiogenesis but Caution Against Wound Healing
  45. Evaluation of basic mitochondrial functions using rat tissue homogenates
  46. Phosphomimetic Substitution of CytochromecTyrosine 48 Decreases Respiration and Binding to Cardiolipin and Abolishes Ability to Trigger Downstream Caspase Activation
  47. Impaired mitochondrial energetic in patients harbouring SURF1 mutations is caused by uncoupling of cytochrome c oxidase
  48. Increased oxidative stress in fibroblasts from patients with ATP synthase deficiency
  49. Regulation of mitochondrial respiration and apoptosis through phosphorylation of cytochrome c
  50. Mitochondrial ATP synthase deficiency due to a mutation in the ATP5E gene for the F1   subunit
  51. A suggested role for mitochondria in Noonan syndrome
  52. Mitochondrial dysfunction in a neural cell model of spinal muscular atrophy
  53. Chapter 11 Isolation of Regulatory‐Competent, Phosphorylated Cytochrome c Oxidase
  54. High efficiency of ROS production by glycerophosphate dehydrogenase in mammalian mitochondria
  55. Regulation of oxidative phosphorylation, the mitochondrial membrane potential, and their role in human disease
  56. HIF and reactive oxygen species regulate oxidative phosphorylation in cancer
  57. Direct linkage of mitochondrial genome variation to risk factors for type 2 diabetes in conplastic strains
  58. Respiratory chain components involved in the glycerophosphate dehydrogenase-dependent ROS production by brown adipose tissue mitochondria
  59. Mitochondrial complex I inhibition in cerebral cortex of immature rats following homocysteic acid-induced seizures
  60. Mitochondrial diseases and genetic defects of ATP synthase
  61. Two components in pathogenic mechanism of mitochondrial ATPase deficiency: Energy deprivation and ROS production
  62. Evaluation of mitochondrial membrane potential using a computerized device with a tetraphenylphosphonium-selective electrode
  63. Inhibition of cytochrome c oxidase subunit 4 precursor processing by the hypoxia mimic cobalt chloride
  64. Flow-cytometric monitoring of mitochondrial depolarisation: from fluorescence intensities to millivolts
  65. Diminished synthesis of subunit a (ATP6) and altered function of ATP synthase and cytochromecoxidase due to the mtDNA 2 bp microdeletion of TA at positions 9205 and 9206
  66. A new role for the von Hippel-Lindau tumor suppressor protein: stimulation of mitochondrial oxidative phosphorylation complex biogenesis
  67. Mitochondrial diseases and ATPase defects of nuclear origin
  68. GUG is an efficient initiation codon to translate the human mitochondrial ATP6 gene
  69. Mitochondrial Membrane Potential and ATP Production in Primary Disorders of ATP Synthase
  70. Functional alteration of cytochrome c oxidase by SURF1 mutations in Leigh syndrome